Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Delorme
Friedhelm Raue

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Thyroid : Official Journal of the American Thyroid Association|March 27, 2015
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinomaSamuel A Wells, Sylvia L Asa, Henning Dralle, et al.
Radiology|August 26, 2009
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imagingTobias Bäuerle, Jens Hillengass, Kerstin Fechtner, et al.
Neoplasia (New York, N.Y.)|May 22, 2004
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101Fabian Kiessling, Nabeel Farhan, Matthias P Lichy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculationJens Hillengass, Christian Zechmann, Tobias Bäuerle, et al.
European Radiology|September 9, 2017
Effect of smoking cessation on quantitative computed tomography in smokers at risk in a lung cancer screening populationBertram J Jobst, Oliver Weinheimer, Mila Trauth, et al.
BMC Cancer|March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trialAnne Katrin Berger, Carl von Gall, Ulrich Abel, et al.
Plos One|March 15, 2014
Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging--a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) cohortsJasmine Neamat-Allah, Diana Wald, Anika Hüsing, et al.
British Journal of Haematology|May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damageMarkus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Investigative Radiology|April 17, 2004
Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial resultsMarc-André Weber, Christoph Thilmann, Matthias P Lichy, et al.
Endocrine-Related Cancer|September 17, 2008
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutationIoana N Milos, Karin Frank-Raue, Nelson Wohllk, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Thyroid : Official Journal of the American Thyroid Association|March 27, 2015
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinomaSamuel A Wells, Sylvia L Asa, Henning Dralle, et al.
Radiology|August 26, 2009
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imagingTobias Bäuerle, Jens Hillengass, Kerstin Fechtner, et al.
Neoplasia (New York, N.Y.)|May 22, 2004
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101Fabian Kiessling, Nabeel Farhan, Matthias P Lichy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculationJens Hillengass, Christian Zechmann, Tobias Bäuerle, et al.
European Radiology|September 9, 2017
Effect of smoking cessation on quantitative computed tomography in smokers at risk in a lung cancer screening populationBertram J Jobst, Oliver Weinheimer, Mila Trauth, et al.
BMC Cancer|March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trialAnne Katrin Berger, Carl von Gall, Ulrich Abel, et al.
Plos One|March 15, 2014
Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging--a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) cohortsJasmine Neamat-Allah, Diana Wald, Anika Hüsing, et al.
British Journal of Haematology|May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damageMarkus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Investigative Radiology|April 17, 2004
Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial resultsMarc-André Weber, Christoph Thilmann, Matthias P Lichy, et al.
Endocrine-Related Cancer|September 17, 2008
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutationIoana N Milos, Karin Frank-Raue, Nelson Wohllk, et al.
Pageof 21